Etiometry Significantly Enhances Platform Capabilities, Extending Insights Beyond the ICU

News and Press Releases

The addition of high-fidelity waveform data integration provides deeper insights and additional data points available in lower-acuity settings

July 8, 2025 – BOSTON – Etiometry, a leader in clinical decision support software, has announced a significant advancement to its platform with the integration of high-fidelity waveform data to inform and improve existing clinical data interpretation.

By leveraging waveform information alongside existing data streams, including patient monitors, peripheral devices, lab results, and medication data—this enhancement offers deeper insights into patient physiology, enabling clinicians to make even more informed decisions at the point of care. Using this robust data stream, Etiometry’s proprietary FDA-cleared algorithms can now generate novel clinical insights beyond the ICU—extending into lower-acuity settings where waveform data serves as the primary source of patient information.

“This new capability marks a pivotal step in expanding the reach of the Etiometry Platform beyond intensive care, supporting clinical surveillance in lower-acuity settings and across transitions of care within the hospital,” said Etiometry President and CEO Shane Cooke. “With these enhancements, Etiometry continues to advance its mission of improving patient outcomes by delivering scalable, data-driven insights throughout the entire continuum of hospital care.”

The enhancements further expand Etiometry’s robust quality improvement (QI) application by storing the high-fidelity waveform data, making it available for ongoing research. At an enterprise level, clinicians are now able to utilize the platform to monitor patients in their end-to-end journey as they transition care settings within the hospital and extract meaningful data insights. The Etiometry QI App has supported more than 150 quality improvement initiatives and research projects, demonstrating the platform’s role in enhancing healthcare delivery and enabling clinicians to drive better patient outcomes.

###

About Etiometry

Founded in 2010, Etiometry is a leader in clinical decision-support software designed to help clinicians in intensive care units make data-driven, proactive decisions. By leveraging advanced analytics and AI-powered insights, the company empowers care teams to detect subtle changes in patient conditions, prevent complications, and improve recovery times.

Etiometry has received 10 FDA clearances and is trusted by leading healthcare institutions worldwide, including top-ranked academic medical centers and pediatric hospitals. The company is committed to advancing patient safety, improving clinical efficiency, and lowering the cost of care through smarter data utilization.

To learn more, visit www.etiometry.com.

Media Contact

Hyedi Nelson
Bellmont Partners
Hyedi@bellmontpartners.com
651-757-7054


Related

Etiometry: Redefining Critical Care Through Intelligent Clinical Decision Support

Critical care generates an overwhelming amount of data. The challenge is turning that data into meaningful action. In this feature, Etiometry CEO Shane Cook discusses how intelligent decision support is helping care teams transform complex patient data into actionable insights by supporting earlier intervention, improved collaboration, and better outcomes. Read more about how we’re helping […]

Do ICUs Need Both EHR and Clinical Intelligence Systems?

Most hospitals running a modern ICU have invested heavily in their EHR. The records are thorough and the system integrates billing, compliance and clinical notes into one place. So the question that hospital leaders regularly ask is a fair one: do we need anything else? The answer, for high-acuity care, is yes. Not because the […]